Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Diagnosing and treating skin conditions is challenging, especially when drug reactions mimic other diseases.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Exosomes could be effective for improving skin health and treating skin diseases.

Cannabinoids may help some skin conditions but more research is needed.

Too much sugar harms skin, causing wrinkles and acne, but a low-sugar diet can help.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

N,N-Dimethylglycine Sodium Salt helps reduce skin inflammation and improves skin cell growth and healing.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Common gene patterns may cause skin autoimmune diseases.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Stem-cell therapy shows promise for skin conditions but needs more research.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.